|
| Exchange Disseminated Time | Lincoln Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 16, 2015, has subject to the approval of the shareholders of the Company at the Extra Ordinary General Meeting to be held on May 15, 2015 and stock exchanges where the shares of the Company are listed, considered and approved, issue of 36,89,200 convertible warrants on preferential basis at price of Rs. 82/- per warrant to the promoters / promoters' group and persons other than the promoters.
Shri Mahendra G. Patel, Managing Director of the Company has been authorized to take appropriate actions in the said matter. |
|
|